Image 1
Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 0093-8310
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 0093-8310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Not available.*
Image 3
Image 4
This is the labeling of Eletriptan Hydrobromide Tablets with usual dosage and storage instructions. It also warns to keep the medication out of reach of children and states the manufacturer and manufacturer's address. The tablets contain 20 mg of eletriptan hydrobromide.*
Image 5
Eletriptan Hydrobromide Tablets are to be stored at controlled room temperature and are child-resistant. Users should consult the package insert for full prescribing information on appropriate dosages. The medication should be kept out of reach of children. The tablets contain 40 mg eletriptan hydrobromide, and the package includes one card with six tablets. The medication is manufactured by Teva Canada Limited and is available in the United States through Teva Pharmaceuticals USA, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
